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Background: Blended face-to-face and Web-based treatment is a promising way to deliver cognitive behavioral therapy. Since
adherence has been shown to be a measure for treatment’s acceptability and a determinant for treatment’s effectiveness, in this
study, we explored adherence to a new blended smoking cessation treatment (BSCT).
Objective: The objective of our study was to (1) develop an adequate method to measure adherence to BSCT; (2) define an
adequate degree of adherence to be used as a threshold for being adherent; (3) estimate adherence to BSCT; and (4) explore the
possible predictors of adherence to BSCT.
Methods: The data of patients (N=75) were analyzed to trace adherence to BSCT delivered at an outpatient smoking cessation
clinic. In total, 18 patient activities (eg, using a Web-based smoking diary tool or responding to counselors’ messages) were
selected to measure adherence; the degree of adherence per patient was compared with quitting success. The minimum degree
of adherence of patients who reported abstinence was examined to define a threshold for the detection of adherent patients. The
number of adherent patients was calculated for each of the 18 selected activities; the degree of adherence over the course of the
treatment was displayed; and the number of patients who were adherent was analyzed. The relationship between adherence and
33 person-, smoking-, and health-related characteristics was examined.
Results: The method for measuring adherence was found to be adequate as adherence to BSCT correlated with self-reported
abstinence (P=.03). Patients reporting abstinence adhered to at least 61% of BSCT. Adherence declined over the course of the
treatment; the percentage of adherent patients per treatment activity ranged from 82% at the start of the treatment to 11%-19%
at the final-third of BSCT; applying a 61% threshold, 18% of the patients were classified as adherent. Marital status and social
modeling were the best independent predictors of adherence. Patients having a partner had 11-times higher odds of being adherent
(OR [odds ratio]=11.3; CI: 1.33-98.99; P=.03). For social modeling, graded from 0 (=partner and friends are not smoking) to 8
(=both partner and nearly all friends are smoking), each unit increase was associated with 28% lower odds of being adherent
(OR=0.72; CI: 0.55-0.94; P=.02).
Conclusions: The current study is the first to explore adherence to a blended face-to-face and Web-based treatment (BSCT)
based on a substantial group of patients. It revealed a rather low adherence rate to BSCT. The method for measuring adherence
to BSCT could be considered adequate because the expected dose-response relationship between adherence and quitting could
be verified. Furthermore, this study revealed that marital status and social modeling were independent predictors of adherence.
Trial Registration: Netherlands Trial Registry NTR5113; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5113
(Archived by WebCite at http://www.webcitation.org/71BAPwER8).
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Introduction
Smoking Cessation Treatment
As smoking is the leading cause of preventable death, cessation
treatment remains pivotal for public health promotion. In past
decades, a variety of effective interventions for smoking
cessation have become available [1,2], including, more recently,
Web-based interventions [3,4] and mobile-phone interventions
[5,6]. Currently, both traditional and Web-based modes of
delivery are being increasingly merged into blended treatment.
Blended Treatment
Blended treatment is a promising way to deliver behavioral
change interventions as it allows combining the strengths of
face-to-face treatment (personal attention of a professional,
allowing for rich and dynamic synchronous communication)
with the unique features of Web-based care (accessibility
anytime and anywhere, self-paced asynchronous
communication) [7-12]. In the recent past, a growing body of
research on blended treatment has emerged [9,13] exploring
diverse aspects such as individual and group treatments [14]
for a number of health issues, such as depression [15], anxiety
[16], and addiction [11]; comparing modes of delivery, such as
mainly Web-based [17,18], mainly face-to-face [16,19], and
50-50 [20]; orders of modes of delivery, such as integrated [11]
and sequential [18]; and tools used, such as platforms, emails,
short message service text messaging, and apps [21,22].
Adherence
While blended treatment may decrease dropout rates [9], it may
also increase adherence, which is often low in both Web-based
and cessation treatments [23]. Adherence can be defined as the
extent to which a person’s behavior—taking medication,
following a diet, or executing lifestyle changes—corresponds
with recommendations from a health care provider [24]. In the
context of behavioral change treatments (eg, smoking cessation
counseling), issues of adherence are mostly related to premature
termination of the treatment and failures to complete
between-session tasks and exercises [25]. Low adherence is
both an indicator for limited treatment acceptability and a
primary determinant of treatment effectiveness [24,26-28]
because it leads to suboptimal exposure of patients to
evidence-based components of treatment, which in
turn—assuming a dose-response relationship—negatively affects
treatment outcome [24].
Adherence to Blended Treatment
Until now, little has been known about adherence to blended
treatment. In a randomized controlled trial (RCT; N=97),
comparing the blended treatment of comorbid mental health
and substance use problems with face-to-face treatment,
participants were found to be equally able to engage, bond, and
commit to treatment [29]. However, in another RCT (N=45),
adherence was significantly lower for blended depression
treatment than for face-to-face treatment (90.5% vs 95.1%),
although both treatments were equally effective [30]. Based on
a small sample (N=9) in another blended depression treatment
trial, adherence rates were considered promising (ie, 5 of 7
patients who started blended treatment completed 90% of it)
[20]. This initial evaluation study also revealed that
discontinuing blended treatment appeared to be unrelated to the
blended nature of the treatment and, unsurprisingly, having
internet access and a functional computer at home was
indispensable. Finally, a case report on blended treatment for
antepartum depression also showed good adherence [31].
In the context of smoking cessation, to the best of our
knowledge, adherence to blended treatment has not been
assessed. For smoking cessation treatment in general, adherence
rates widely vary between studies (5%-96%), which can be
explained by differences in the interventions used, adjunctive
support, and populations studied [24]. Typically, in a smoking
cessation treatment, adherence rapidly declines over the initial
weeks of treatment, followed by a more gradual decrease in the
later stages, resulting in rather low adherence rates (<40%) [24].
Predictors of Adherence
As adherence is pivotal for treatment effectiveness [24],
predicting adherence becomes relevant because it may increase
treatment efficacy. Adherence, in general, is determined by
provider behaviors, health system factors, and personal
characteristics [24]. In particular, the latter have been examined
as predictors of adherence to traditional interventions [32].
However, similar studies on adherence to blended treatment
appear to be lacking. Within the context of smoking cessation
treatment—including both face-to-face and Web-based
treatments—several person-, smoking-, and health-related
predictors of adherence have been examined. The likelihood of
being adherent increases with a higher age [33,34], male gender
[34], higher internet skills [35,36], negative attitude toward
smoking and higher motivation to quit at baseline [37,38], higher
self-efficacy at baseline [38], early success in quitting after the
start of the treatment [26,33,39], and lower nicotine dependency
at baseline and fewer withdrawal symptoms after quitting
[34,37]. The question arises whether these predictors apply to
blended treatment as well.
Measurement of Adherence
To examine the predictors of adherence, valid measurement of
adherence becomes a prerequisite. Taking into account both the
novelty and diversity of blended treatments, one can understand
that established measures for adherence to blended treatment
in particular are still lacking. Therefore, for the purpose of this
study, a customized measure was constructed based on a
combination of parameters used for face-to-face and Web-based
interventions. In face-to-face treatment, adherence is often
operationalized as completion of tasks assigned during the
treatment or the number of completed or attended treatment
sessions [40]. In Web-based treatment, the measures of
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adherence often comprise log-ins to programs, module
completion, time spent online, (self-reported) completion of
predefined activities such as use of an Web-based tool, posts
made, pages viewed, replies to emails, forum visits, or print
requests made [23]. Aiming to increase precision and accuracy,
the adherence measure developed for this study was primarily
based on objective or direct adherence indicators, such as
whether or not a patient attended a face-to-face session,
responded to a counselor’s message, or used a certain Web-based
treatment tool (eg, “goal setting” or “think differently”). Using
observable and digitally traceable patient activities, limitations
in terms of reliability and validity of self-report data [41] can
be largely avoided.
Thresholds Defining “Adequate” and “Inadequate”
Adherence
Finally, in addition to measuring adherence as a continuous
variable, applying a categorical measure based on a threshold
for “adequate” and “inadequate” adherence may be useful for
clinical purposes [32]. However, justifications for the
operationalizations of thresholds are a common issue; a recent
review [42] on adherence to eHealth revealed that 28 of 62
studies described thresholds, but only 6 reported a justification
for the threshold. In line with Carolan [43], in this study, we
have defined the threshold in relation to the treatment outcome
(ie, quitting smoking). To the best of our knowledge, neither
for blended smoking cessation treatment (BSCT), in particular,
nor for blended treatment, in general, have the thresholds for
adherence been explored until now. In the context of smoking
cessation, intervention thresholds for classifying participants
as adherent or nonadherent range from 75% to 100% use of
intervention components offered [24].
Objectives
In view of all that has been mentioned so far, the objectives of
this exploratory study were as follows:
1. To develop a method to measure adherence to a BSCT by
selecting traceable activities of the patients and to determine
whether this method is adequate by comparing the degree
of adherence with the quitting success (ie, verifying the
expected dose-response relationship between adherence
and quitting).
2. To define an adequate degree of adherence to be used as a
threshold to detect adherent patients by examining the
minimum degree of adherence of the patients who reported
abstinence.
3. To estimate adherence to BSCT in three ways: by
calculating the number of adherent patients for certain
treatment activities; by displaying how the degree of
adherence changes over the course of the treatment; and by
reporting the proportion of adherent patients according to
the threshold for adherence.
4. To explore the possible predictors of adherence to BSCT
by examining the relationship between being adherent or
nonadherent and 33 person-, smoking-, and health-related
characteristics assessed at baseline.
Methods
Study Participants
In this study, we used a subset of an RCT on the effectiveness
of BSCT versus face-to-face treatment as usual [11]. Patients
were referred to the outpatient smoking cessation clinic at the
Medical Spectrum Twente hospital (Enschede or The
Netherlands) by the treating physicians of the hospital or by the
patients’ general practitioners. Inclusion criteria included (1)
being at least 18 years old, (2) currently smoking (at least one
cigarette a day), (3) having access to email and internet, (4)
being able to read and write Dutch. For the adherence analysis,
we used the RCT data of the first 75 patients of the BSCT who
attended an initial treatment session from May 2015 to
December 2016. In line with the Dutch Medical Research Ethics
Committee (MREC) guidelines, the study was approved by the
accredited MREC Twente (P14-37/NL50944.044.14). Before
initiation, the study was registered in the Dutch Trial
Registration (NTR5113). All patients had to sign an informed
consent form before they were randomized.
Blended Smoking Cessation Treatment
The BSCT examined in this study is a combination of
face-to-face treatment and Web-based sessions blended into
one integrated smoking cessation treatment, which is delivered
in routine care settings. BSCT consists of 5 face-to-face sessions
at the outpatient clinic and 5 Web-based sessions delivered via
the Web-based treatment platform. Table 1 shows the order,
timing, main features, and mode of delivery of the sessions.
The following are the characteristic features of BSCT:
1. High-intensity treatment: BSCT comprises 10 sessions (20
minutes each, except the first one, which is of 50 minutes);
it covers the majority of evidence-based behavior change
techniques [44]. It is derived from the Dutch Guideline
Tobacco Addiction [45], fulfilling the requirements of the
Dutch care module for smoking cessation [46]; the
counselors are registered in the Dutch quality register of
qualified smoking cessation counselors.
2. Supports three quitting strategies: At the start, patients
choose to (1) stop at once, (2) change gradually by
increasing the number of daily activities that are performed
smoke-free, or (3) decrease smoking at regular intervals
(scheduled smoking reduction, eg, 100%->75%,
75%->50%). The chosen quitting strategy does not influence
the course of the treatment in general, that is, the order,
pace, duration, and intensity are the same for all strategies.
3. A 50-50 balance between face-to-face and Web-based
treatments: The focus of the treatment is neither on
face-to-face nor on Web-based treatment; in addition, the
treatment is constantly alternating and there is interactive
use of face-to-face and Web-based treatments.
A detailed description of the treatment can be found in the
protocol article of the RCT [11].
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Table 1. Order, timing, main features, and mode of delivery of blended smoking cessation treatment.
Mode of deliveryMain featuresWeekSession






Face-to-faceThink differently, measure CO147
Web-basedDo differently188




Patients’ Characteristics and Smoking Status
As part of the RCT, 33 person-, smoking-, and health-related
characteristics were assessed with the intake measurement using
a Web-based questionnaire. A detailed description of these
characteristics is available in the protocol article of the RCT
[11]. In addition, both the 3-month and 6-month follow-up
measurements of the trial were used to examine the self-reported
smoking status.
Measuring Adherence to Blended Smoking Cessation
Treatment
Two data sources were screened to determine which treatment
activities of the patients could be traced after the first treatment
session:
1. The patients’ record from the Web-based treatment
platform. These records provided, on the one hand, a section
where patients and counselors communicated via messages
and, on the other hand, a section with therapeutic
Web-based tools that were used by the patient. Both sections
interact with each other. Here is a typical example of this
interaction: The counselor sends a message with instructions
to use a therapeutic Web-based tool, such as “goal setting.”
With this message, the counselor also unblocks the goal
setting Web-based tool and sets a date for executing this
task. After receiving this message, the patient uses the
unblocked Web-based tool to elaborate goals. What the
patient fills in can then be reviewed by the counselor, who
also has access to the tool. The counselor then usually
responds to what the patient filled in via a message and
leads into the following face-to-face session.
2. Patients’ records from the outpatient cessation clinic, which
were maintained by the counselors. These records provided
additional information about patients’ activities, such as
adhering to a stop-date or measurement of CO.
After comparing the treatment manual with the data available
in the two data sources, 18 activities of patients were selected
to score adherence after the first treatment session. The selection
of activities was based on the following three considerations:
1. The activity had to refer directly to a relevant
evidence-based behavior change technique [44] (eg, goal
setting, action plan) that represented the main feature of the
sessions, so that adherence to each of the 10 sessions of the
treatment was separately measurable.
2. The activities had to trace both face-to-face and Web-based
behaviors of patients (eg, attending face-to-face treatment
sessions as in “Think differently [face-to-face]” or
completion of predefined Web-based tasks as in “Think
differently [Web]”), so that adherence to the constant
interaction between face-to-face and Web-based
treatments—and by this, the blended nature of BSCT—was
covered.
3. The data used had to be objective (eg, receiving a message,
unblocking a Web-based tool, filling in a minimal number
of data in a Web-based tool) to avoid the limitations of
self-reported data [41].
The majority of the selected activities reflected the course of
the blended treatment, starting with “Goal setting (face-to-face)”
at the end of session 1 and finalizing with “Action plan (Web)”
in session 10. Three activities were not session dependent as
they had to be executed several times (“Measurement of CO
[face-to-face]”) or across several sessions (“smoking diary [days;
Web]”; “smoking diary [moments; Web]”). A detailed
description of these activities showing how each activity was
operationalized to indicate adherence or nonadherence is
provided in Table 2.
Based on data sources, for each patient, adherence to each of
the 18 activities was assessed and graded adherent or
nonadherent by trained research assistants. Finally, for each
patient, an adherence score from 0 (adherent to no activity after
the first treatment session) to 18 (adherent to all activities) as
well as subscores for Web-based versus face-to-face and
session-dependent versus session-independent activities were
available.
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Table 2. Activities, operationalization, and patients’ adherence to blended smoking cessation treatment (N=75).
Adherent patients, n (%)OperationalizationActivity and mode of delivery
Session-dependent activities
Session 1: Goal setting
62 (82)The patient was introduced to “goal setting” and received a message with
the prompt to use the Web-based goal setting tool.
Face-to-face treatment
44 (58)The patient used the Web-based goal setting tool.Web-based treatment
Session 2: Measures for self-control
39 (52)The patient was introduced to “measure for self-control” and received a
message with information about measures for self-control.
Face-to-face treatment
27 (36)The patient reacted to the measure for self-control message. (Note: a re-
sponse was not obligatory; patients could read only without responding)
Web-based treatment
Session 3: Dealing with withdrawal
31 (41)The patient was introduced to “dealing with withdrawal” and received
a message with information about dealing with withdrawal.
Face-to-face treatment
20 (26)The patient reacted to the dealing with withdrawal message. (Note: a
response was not obligatory; patients could read only without responding)
Web-based treatment
Session 5: Dealing with tempters
22 (29)The patient received a message with information about dealing with
tempters.
Web-based treatment
Session 6: Food for thought
17 (23)The patient was introduced to “food for thought” and received a message
with information about food for thought.
Face-to-face treatment
8 (11)The patient reacted to the food for thought message (Note: a response
was not obligatory; patients could read only without responding)
Web-based treatment
Session 7: Think differently
14 (19)The patient was introduced to “think differently” and received a message
with the prompt to use the Web-based think differently tool.
Face-to-face treatment
14 (19)The patient used the Web-based think differently tool.Web-based treatment
Session 8: Do differently
12 (16)The patient was introduced to “do differently” and received a message
with the prompt to use the Web-based do differently tool.
Face-to-face treatment
14 (19)The patient used the Web-based do differently tool.Web-based treatment
Session 9: Action plan
13 (17)The patient was introduced to “action plan” and received a message with
the prompt to use the Web-based action plan tool.
Face-to-face treatment
Session 10: Action plan
13 (17)The patient used the Web-based action plan tool.Web-based treatment
Session-independent activities
34 (45)The counselor reported at least 2 CO measurements.Measurement of COa (face-to-face
treatment)
26 (35)The patient used the Web-based smoking diary tool registering cigarettes
smoked for at least 3 days.
Smoking diary (days; Web)
31 (41)The patient used the Web-based smoking diary tool describing at least
3 moments with an urge to smoke.
Smoking diary (moments; Web)
aCO: carbon monoxide.
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Patients’ person-, smoking-, and health-related characteristics
were reported as means with SDs for normally distributed
continuous variables and as medians with interquartile ranges
(IQRs) for not-normally distributed continuous variables.
Categorical variables were reported as numbers with
corresponding percentages.
Dose-Response Relationship Between Adherence and
Quitting
To explore the association between the degree of adherence and
quitting success, the median number of adherence activities was
compared between quitters (based on self-reported smoking
status) and smokers at 3 and 6 months after the start of the
treatment and tested using Mann-Whitney-U test.
Threshold to Detect Adherent Patients
To define a threshold for an adequate degree of adherence, the
minimum number of adherence activities of quitters (6 months
after the start of the treatment) was examined and displayed as
number (%) of activities for BSCT overall and separately for
both face-to-face and Web-related activities.
Adherence to Blended Smoking Cessation Treatment
Adherence per Activity
To examine the degree of adherence to each of the BSCT
activities, the number (%) of patients fulfilling each activity
was examined and displayed separately.
Adherence Over the Course of the Treatment
To show changes in adherence over the course of the treatment,
the number of patients who were adherent to session-dependent
activities was displayed in a bar chart.
Adherence Based on the Threshold
The number (%) of patients who were adherent and nonadherent
based on the determined threshold to detect adherent patients
was cross-tabulated for both the face-to-face and Web-based
modes. The number of adherent patients was compared between
face-to-face and Web-based treatments and tested using Pearson
chi-square test.
Predictors of Adherence
To identify the predictors of adherence within the 33 person-,
smoking-, and health-related patient characteristics, t tests or
Mann-Whitney-U tests were performed as appropriate for
continuous variables; Pearson chi-square or Fisher’s exact test
were performed for categorical variables. Variables with a
significance P<.15 were considered as the candidates for
multivariate logistic regression analyses and were entered after
checking for multicollinearity. Forward stepwise logistic
regression analyses were performed. Variables were entered
step for step and were eliminated when the model fit was not
significantly increased by adding the variable (based on −2 log
likelihood). In case of multicollinearity, the variable with the
best model fit was selected for logistic regression analyses.
Statistical Analysis
All analyses were performed using SPSS version 24.
Results
Patients’ Characteristics
Patients’ person-, smoking-, and health-related characteristics
are shown in Multimedia Appendix 1.
Dose-Response Relationship Between Adherence and
Quitting
A subsample of patients’ self-reported smoking status at 3
months (n=25) and 6 months (n=17) after the start of the
treatment was available to explore the relationship between
adherence and quitting. As can be seen by the numbers of
activities for adherence tabulated in Table 3, there is a
dose-response relationship between adherence to BSCT and
self-reported smoking status at 3 and 6 months after the start of
the treatment. The median number of activities for adherence
is significantly higher among quitters at 6 months after the start
of the treatment (P=.03).
Threshold to Detect Adherent Patients
Patients with self-reported abstinence at 6 months after the start
of the treatment (n=17) were adherent to at least 61% (11/18)
activities of BSCT. Because BSCT is built on a 50%-50%
relation for both modes of delivery, a 61% threshold was applied
to both modes of delivery to detect adherent patients (ie, patients
were defined as adherent if 5 of the 8 face-to-face activities as
well as 6 of the 10 Web-based activities were fulfilled).
Adherence to Blended Smoking Cessation Treatment
Adherence per Activity
Table 2 shows the number (%) of adherent patients for each
activity. Of all, 17.3% (13/75) patients were adherent to none
of the activities, which indicates that these patients did not fully
complete the first face-to-face session that closes with the patient
being introduced to “goal setting” and receiving a message with
the prompt to use the Web-based goal setting tool. None of the
patients were adherent to all activities.
Adherence per Activity Over the Course of Treatment
To show the change in adherence over the course of the
treatment, the number of adherent patients per session-dependent
activity (excluding the 3 session-independent activities) is
displayed in a bar chart (Figure 1). The number of adherent
patients was highest at the start of the treatment (62/75, 82%,
patients adherent to “Goal setting [face-to-face]”). Adherence
then decreased to 11% (8/75) for the activity “Food for thought
(Web),” which is in the 6thtreatment session (Table 2), staying
at a low level for the rest of the treatment (varying between
12/75, 16%, and 14/75, 19%).
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Table 3. Adherence to blended smoking cessation treatment and self-reported smoking status at 3 and 6 months after the start of the treatment.
P valueMedian number of adherence activities (IQRa)Time point
SmokerQuitter
.089.0 (6.0-14.0)14.5 (9.5-15.8)3 months (n=25)
.039.0 (6.5-14.5)15.0 (11.8-16.0)6 months (n=17)
aIQR: interquartile range.
Figure 1. Adherence over the course of the treatment. f2f: face-to-face.
Table 4. Adherence to blended smoking cessation treatment based on the 61% threshold (N=75). Percentages are based on the overall N value.
Web-basedFace-to-face
Total n (%)Nonadherent n (%)Adherent n (%)
19 (25)5 (7)14 (18)Adherent
56 (75)53 (70)3 (5)Nonadherent
75 (100)58 (77)17 (23)Total
Adherence Based on the Threshold
Based on the 61% threshold for both modes of delivery, 18%
(14/75) patients were adherent to both modes of delivery and,
therefore, to BSCT as a whole (Table 4). Of all, 25% (19/75)
patients were adherent to the face-to-face treatment compared
with 23% (17/75) adherent to the Web-based treatment (P=.70);
70% (53/75) patients were nonadherent to both modes of
delivery. Furthermore, 5% (3/75) patients were adherent to the
Web-based mode but not to the face-to-face mode, while 7%
(5/75) patients were adherent to the face-to-face mode but not
to the Web-based mode.
Predictors of Adherence
The 33 person-, smoking-, and health-related characteristics of
the 75 patients, stratified by the 61% adherence or nonadherence
threshold, are shown in Multimedia Appendix 1.
The following predictors were univariately associated with
adherence (P<.15): sex (male = more adherent); marital status
(with partner = more adherent); main income (wage or own
company = more adherent); social modeling (less smokers in
the social environment = more adherent) and use of alcohol
(higher alcohol consumption = more adherent); use of other
medication (user = more adherent); health-related complaints
(as per Maudsley Addiction Profile Health Symptoms Scale
[MAP HSS]), smoking-related complaints, and health- and
smoking-related complaints (less complaints = more adherent).
Due to multicollinearity between health-related complaints
(MAP HSS), smoking-related complaints, and health- and
smoking-related complaints, only the variable with the best
model fit could be included in multivariate regression analysis,
which was health- and smoking-related complaints.
J Med Internet Res 2018 | vol. 20 | iss. 8 | e246 | p.7http://www.jmir.org/2018/8/e246/
(page number not for citation purposes)
Siemer et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Multivariate regression analyses revealed that marital status and
social modeling—accounting for 25% of the variance
(Nagelkerke R Square)—were independent predictors of whether
patients were adherent to BSCT. Patients having a partner had
11 times higher odds of being adherent, although the extremely
wide CI indicates considerable uncertainty for this odds ratio
(OR=11.3; CI: 1.33-98.99; P=.03). For social modeling, graded
from 0 (=partner and friends are not smoking) to 8 (=both
partner and nearly all friends are smoking), each unit increase
was associated with 28% lower odds of being adherent
(OR=0.72; CI: 0.55-0.94; P=.02).
Discussion
Principal Findings
This study is the first to explore adherence to a blended
face-to-face and Web-based smoking cessation treatment
(BSCT). Based on a substantial group of participants (N=75),
the study revealed a rather low adherence rate to BSCT among
this sample of outpatients in a regional hospital in the
Netherlands. Applying a 61% threshold for adherence to both
face-to-face and Web-based modes of delivery, only 18%
(14/75) of the participants were classified as adherent. A
dose-response relationship was found between the level of
adherence and the likelihood of quitting smoking, corroborating
the adequacy of the adherence measure developed for this
purpose. Furthermore, several baseline characteristics, in
particular marital status and social modeling of nonsmoking,
were found to be predictive of adherence to BSCT.
So far, the established measures for adherence to blended
treatment are still lacking. Therefore, the first aim of this study
was to develop an adequate method for measuring adherence
to BSCT and to determine whether this method is adequate.
Using data from the hospital’s patient records and data logged
by patients and counselors on the Web-based treatment platform,
a composite score of adherence to 18 distinct treatment activities
from both the modes of delivery was calculated. By relying on
observed behavior, an objective approach was applied, thus,
avoiding bias due to self-report [41]. Adequacy of the adherence
measure was confirmed by the observed dose-response
relationship between adherence and likelihood of quitting, which
is consistent with smoking cessation literature [24,26-28].
A justified threshold for “adequate” and “inadequate” adherence
may be useful for clinical purposes [32]. Hence, the second aim
of the study was to define an adequate level of adherence to be
used as a threshold to detect patients adherent to BSCT. We
used a 61% threshold, which is derived from the minimum level
of adherence of the patients reporting abstinence. Although this
61% threshold is considerably lower than the commonly applied
thresholds of >80% in the previous studies [33,47], it seems
realistic if the design of BSCT is taken into consideration. As
BSCT is designed as a 10-session, high-intensity treatment, its
completion might pose a challenge to the patients of the
outpatient clinic. Furthermore, BSCT fosters quitting around
month 3 of the treatment while focusing on stabilizing
abstinence in the remaining 3 months. Although patients are
informed that relapse prevention is pivotal in the later parts of
treatment, there seems to be a tipping point at around 60% of
the treatment course at which some of the patients who have
been successful until then, decide to abandon treatment, thinking
themselves “over the hump.” This may also be explained by the
bidirectional causality between quitting and adherence: early
quitting success predicts adherence [33], while, in turn,
adherence predicts (long-term) abstinence [24,26-28].
Because, until now, little has been known about adherence to
blended treatment, the third aim of the study was to estimate
adherence to BSCT. Not surprisingly, we found a notable
decrease in adherence over the course of the treatment. Only a
small proportion of patients (12/75, 16%, to 14/75, 19%) was
adherent to the last 4 of the 10 BSCT sessions. This is in line
with the <40% adherence rates for the later stages of smoking
cessation treatment in general [24].
Based on the 61% threshold derived from self-reported
abstinence, we found that only 18% (14/75) of the patients were
adherent to BSCT. This adherence rate seems to be notably
lower than the adherence rates reported in smoking cessation
literature, which—while applying even higher thresholds—range
from, for example, 50% for Web-based treatment [47] to 70%
for face-to-face smoking cessation treatment [34]. Explanations
for the low adherence may be negative user experience (eg, due
to too demanding or time-consuming features) or lack of
persuasive elements [48] in the Web-based treatment.
We also found no significant difference in adherence to
Web-based and face-to-face modalities. This is in line with
earlier findings, showing that discontinuing the blended
treatment is unrelated to the blended nature of the treatment
[20].
Since predicting adherence may increase treatment efficacy, the
fourth aim of the study was to find the predictors of adherence
to BSCT. We found being adherent to be significantly (P ≤.05)
related to male gender, having a partner, wage or own company
as the source of main income, and having a low number of
smokers in the social environment. Except for gender [34], we
could not confirm predictors earlier reported in the literature,
such as age [33,34], internet skills [35,36], attitude toward
smoking and motivation to quit [37,38], self-efficacy [38], and
nicotine dependency and withdrawal symptoms [34,37].
Furthermore, we found potential predictors of adherence to
BSCT (P ≥.05-.15) not earlier reported in the context of smoking
cessation treatment, namely use of alcohol, use of other
medication, and health- and/or smoking-related complaints.
Two predictors—having a partner and having a low number of
smokers in the social environment—were found to be unique,
independent predictors in the multivariate predictor model.
Having a partner gave higher odds of being adherent than living
alone. Although not earlier reported in the context of smoking
cessation, this seems to be consistent with a meta-analysis about
marital status and adherence to medical treatment in general,
which found 1.27 (CI: 1.12-1.43) times higher odds of adherence
in married than in unmarried patients [49]. The most common
explanation for this effect of marital status is the social support
that a partner may provide to the patient. However, within this
study, we did not find a predictive effect of social support, which
included the partner as an important other. It should be noted,
however, that the measure for social support was specified for
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smoking cessation and not for adherence. Future research is
needed to clarify these inconsistencies. The remarkably high
OR of 11 for marital status should be interpreted cautiously
because the CI for this ratio was very wide, probably due to
limited statistical power in our data. For social modeling, graded
from 0 (=partner and friends are not smoking) to 8 (=both
partner and nearly all friends are smoking), each unit increase
gave 28% lower odds of being adherent. Although not previously
reported as a predictor of adherence, social modeling is well
known as one of the main determinants of relapse [50-52].
Apparently, patients with more smokers in their environments
have a higher probability to relapse; consequently, they drop
out of treatment, resulting in lower adherence. This would also
be in line with the bidirectional causality between quitting and
adherence mentioned above. Looking at social modeling as a
relevant predictor of adherence to BSCT, as a clinical
implication, the treatment could offer more normative influence
(eg, showing videos of peers praising quit attempts of others to
patients who report high social modeling of smoking in their
environment).
Limitations
A major limitation of this study is that the results found for
BSCT have not been compared with either a face-to-face only
or a Web-based only treatment. Therefore, it remains undecided
whether the results are specific for the blended nature of the
treatment or rather for smoking cessation treatment in general.
In addition, the statistical power in this study—especially for
predictor analysis—is rather low. This implies, in particular,
that false-negative results may have occurred for predictors with
small to medium observed effect sizes. As the purpose of this
study is primarily exploratory, the risk of false-negative findings
was reduced by also considering marginally significant effects
as “potential” predictors. However, caution should be taken
here, and replication of these findings in future studies is needed.
Furthermore, the adequacy of the adherence measure can be
questioned on three aspects. First, 3 of the 10 Web-based
activities, “Measure for self-control,” “Dealing with
withdrawal,” and “Food for thought,” involved written messages
sent by counselors prompting a response by, for example, asking
a question at the end of the message. Only when a patient
responded and left a traceable action, the activity was scored as
completed. Yet, patients may still have read the received
messages without explicitly responding to the counselor. This
may have led to an underestimation of adherence because the
patient may have been exposed to some components without
notable traces. Second, the data from the hospital’s patient
records and the Web-based treatment platform partly depend
on activities of the counselors because they maintain these
patients’ records and also act on the Web-based treatment
platform (eg, sending messages to patients, unblocking treatment
tools). One can argue, therefore, that adherence measurement
is affected by treatment fidelity of counselors. Fidelity of
counselors was not evaluated—a common omission in adherence
studies [53]. Given that, in this particular case, BSCT was new
to the counselors, and their potential unfamiliarity with BSCT
may have led to not following the treatment protocol strictly.
This may also be increased by therapist drift [54], a common
phenomenon in face-to-face cognitive behavioral therapy, which
involves a shift from “doing therapies” to “talking therapies.”
Third, although striving for objective measures, whether an
activity was fulfilled by a patient was doubtful in some cases;
for example, the use of the Web-based goal setting tool was
questionable if only one word to set a goal (eg, “health”) was
sufficient. These cases had to be discussed in the research team,
which adds a subjective factor to the measurement. However,
this was only the case for a very small number of participants,
mainly in the starting phase of data collection.
Finally, the comparability of the observed adherence rates and
thresholds across studies is limited due to variety in treatment
demands and operationalizations of adherence [32].
Implication for Future Work
To assess whether the results found in this study are specific
for the blended nature of BSCT, the results should be compared
with either face-to-face only or Web-based only treatment.
Furthermore, future adherence studies should preferably include
a measure of fidelity as well, enabling analyses that control for
provider-mediated effects on adherence. In addition, from a
clinical perspective, the question arises as to how the low
adherence rate to BSCT can be increased by, on the one hand,
targeting patients to predictive characteristics at baseline or, on
the other hand, redesigning BSCT to better accommodate current
population characteristics and needs.
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